These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17184573)

  • 1. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
    Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
    Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
    Xiong CM; He JG; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):370-4. PubMed ID: 21418907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
    Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
    Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
    Kothari SS; Duggal B
    Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
    Gupta A; Kerkar P
    Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
    Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
    J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.
    Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC
    Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil for primary and secondary pulmonary hypertension.
    Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
    Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
    Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
    Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
    Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
    Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
    J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
    Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
    Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension.
    Apitz C; Reyes JT; Holtby H; Humpl T; Redington AN
    J Am Coll Cardiol; 2010 Apr; 55(14):1456-62. PubMed ID: 20359596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.
    Sastry BK; Narasimhan C; Reddy NK; Anand B; Prakash GS; Raju PR; Kumar DN
    Indian Heart J; 2002; 54(4):410-4. PubMed ID: 12462670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.